INDOCO REMEDIES
Back to Cashflow Statement
|
INDOCO REMEDIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-77 Cr | ₹241 Cr | ₹280 Cr | ₹23 Cr | ₹-44 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDOCO REMEDIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-77 Cr |
| Mar2025 | ₹241 Cr |
| Mar2024 | ₹280 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹-44 Cr |
How is Cash Flow from Financing Activities of INDOCO REMEDIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-77 Cr | Negative | |
| Mar2025 | ₹241 Cr | -13.91 | |
| Mar2024 | ₹280 Cr | 1,129.76 | |
| Mar2023 | ₹23 Cr | Positive | |
| Mar2022 | ₹-44 Cr | - | |
Compare Cash Flow from Financing Activities of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,299.2 Cr | -2.1% | 2.8% | -14.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -2.1% |
2.8% |
-14.9% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses